Bayer poaches GlaxoSmithKline exec to lead expanding oncology business—including a blockbuster hopefulnews2022-02-07T15:45:46+00:00February 7th, 2022|Fierce Pharma|
FDA lifts domestic inspection pause as omicron numbers begin to wanenews2022-02-07T15:14:44+00:00February 7th, 2022|Fierce Pharma|
FDA probes TG Therapeutics’ Ukoniq over potential for elevated death risks 1 year after drug’s approvalnews2022-02-07T15:13:03+00:00February 7th, 2022|Fierce Pharma|
Oxford Biomedica raises $53M to support recent buy into US viral vector manufacturer: reportnews2022-02-07T14:20:09+00:00February 7th, 2022|Fierce Pharma|
Shkreli must stay mum on pharma after judge upholds lifetime industry bannews2022-02-07T13:43:55+00:00February 7th, 2022|Fierce Pharma|
Sanofi’s simplified brand opens a fresh chapter as new strategy, pandemic help turn the pagenews2022-02-07T13:06:36+00:00February 7th, 2022|Fierce Pharma|
Tiziana rethinks oral antibody trial amid feasibility problemsnews2022-02-07T10:57:07+00:00February 7th, 2022|Fierce Pharma|
Moffitt Dyves back into tumor pH modulation, turning to transdermal delivery to bypass oral barriersnews2022-02-07T10:52:59+00:00February 7th, 2022|Fierce Pharma|
Celltrion races inhaled COVID-19 antibody therapy into phase 3 to counter omicronnews2022-02-07T10:47:48+00:00February 7th, 2022|Fierce Pharma|
GSK finds Americans missed 37M routine vaccinations amid pandemicnews2022-02-05T03:34:27+00:00February 5th, 2022|Fierce Pharma|
